Thalassemia Bal Sewa Yojna

Union Health Minister launches 2nd phase of “Thalassemia Bal Sewa Yojna”
Launched in 2017, this scheme is a Coal India CSR funded Hematopoietic Stem Cell Transplantation (HSCT) program.
The CSR initiative was targeted to provide financial assistance to a total of 200 patients by providing a package cost not exceeding Rs. 10 lakhs per HSCT.
It aims to provide a one-time cure opportunity for Haemoglobinopathies like Thalassaemia and Sickle Cell Disease for patients who have a matched family donor.
Thalassemia It is a chronic blood disorder.
It is a genetic disorderdue to which a patient cannot make enough hemoglobin found in Red Blood Cells (RBC’s).
This leads to anemia and patients also require blood transfusions every two to three weeks to survive.
India is the thalassaemia capital of the world with 40 million carriers and over 1,00,000 thalassaemia majors under blood transfusion every month.